List of Tables
    Table 1. Genetic Engineering Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Genetic Engineering Drug Market Trends
    Table 3. Genetic Engineering Drug Market Drivers
    Table 4. Genetic Engineering Drug Market Challenges
    Table 5. Genetic Engineering Drug Market Restraints
    Table 6. Global Genetic Engineering Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Genetic Engineering Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Genetic Engineering Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Genetic Engineering Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Genetic Engineering Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Genetic Engineering Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Genetic Engineering Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Genetic Engineering Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Genetic Engineering Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Genetic Engineering Drug Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Genetic Engineering Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Engineering Drug as of 2021)
    Table 18. Top Players of Genetic Engineering Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Genetic Engineering Drug Product Type
    Table 20. Date of International Manufacturers Enter into Genetic Engineering Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Genetic Engineering Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Genetic Engineering Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Genetic Engineering Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Genetic Engineering Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Genetic Engineering Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Genetic Engineering Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Genetic Engineering Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Genetic Engineering Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Genetic Engineering Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Genetic Engineering Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Genetic Engineering Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Genetic Engineering Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Genetic Engineering Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Genetic Engineering Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Genetic Engineering Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Genetic Engineering Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Genetic Engineering Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Genetic Engineering Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Genetic Engineering Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Genetic Engineering Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Shanghai Lansheng Guojian Pharmaceutical Corporation Information
    Table 43. Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview
    Table 44. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product
    Table 46. Shanghai Lansheng Guojian Pharmaceutical Recent Development
    Table 47. Biotech Pharmaceutical Corporation Information
    Table 48. Biotech Pharmaceutical Description and Business Overview
    Table 49. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Biotech Pharmaceutical Product
    Table 51. Biotech Pharmaceutical Recent Development
    Table 52. Anhui Anke Biotechnology Corporation Information
    Table 53. Anhui Anke Biotechnology Description and Business Overview
    Table 54. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Anhui Anke Biotechnology Product
    Table 56. Anhui Anke Biotechnology Recent Development
    Table 57. GeneScience Pharmaceuticals Corporation Information
    Table 58. GeneScience Pharmaceuticals Description and Business Overview
    Table 59. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. GeneScience Pharmaceuticals Product
    Table 61. GeneScience Pharmaceuticals Recent Development
    Table 62. Beijing SL Pharmaceutical Corporation Information
    Table 63. Beijing SL Pharmaceutical Description and Business Overview
    Table 64. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Beijing SL Pharmaceutical Product
    Table 66. Beijing SL Pharmaceutical Recent Development
    Table 67. Jiangsu Sihuan Bioengineering Corporation Information
    Table 68. Jiangsu Sihuan Bioengineering Description and Business Overview
    Table 69. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Jiangsu Sihuan Bioengineering Product
    Table 71. Jiangsu Sihuan Bioengineering Recent Development
    Table 72. Shenzhen Neptunus Interlong Bio-Technique Corporation Information
    Table 73. Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview
    Table 74. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Shenzhen Neptunus Interlong Bio-Technique Product
    Table 76. Shenzhen Neptunus Interlong Bio-Technique Recent Development
    Table 77. 3SBio Corporation Information
    Table 78. 3SBio Description and Business Overview
    Table 79. 3SBio Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. 3SBio Product
    Table 81. 3SBio Recent Development
    Table 82. Tonghua Dongbao Pharmaceutical Corporation Information
    Table 83. Tonghua Dongbao Pharmaceutical Description and Business Overview
    Table 84. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Tonghua Dongbao Pharmaceutical Product
    Table 86. Tonghua Dongbao Pharmaceutical Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Genetic Engineering Drug Customers List
    Table 90. Genetic Engineering Drug Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Genetic Engineering Drug Product Picture
    Figure 2. Global Genetic Engineering Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Genetic Engineering Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Genetic Engineering Drug Sales 2017-2028 (K Units)
    Figure 5. United States Genetic Engineering Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Genetic Engineering Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Genetic Engineering Drug Sales 2017-2028 (K Units)
    Figure 8. United States Genetic Engineering Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Genetic Engineering Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Genetic Engineering Drug Report Years Considered
    Figure 11. Product Picture of Monoclonal Antibody
    Figure 12. Product Picture of Recombinant Human Erythropoietin
    Figure 13. Product Picture of Recombinant Human Interferon
    Figure 14. Product Picture of Recombinant Human Growth Hormone
    Figure 15. Product Picture of Recombinant Human Insulin
    Figure 16. Global Genetic Engineering Drug Market Share by Type in 2022 & 2028
    Figure 17. Global Genetic Engineering Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Genetic Engineering Drug Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Genetic Engineering Drug Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Genetic Engineering Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Genetic Engineering Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Genetic Engineering Drug Market Share by Type in 2022 & 2028
    Figure 23. United States Genetic Engineering Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Genetic Engineering Drug Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Genetic Engineering Drug Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Genetic Engineering Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Genetic Engineering Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Medicine
    Figure 29. Product Picture of Research
    Figure 30. Product Picture of Industrial
    Figure 31. Product Picture of Agriculture
    Figure 32. Product Picture of Other
    Figure 33. Global Genetic Engineering Drug Market Share by Application in 2022 & 2028
    Figure 34. Global Genetic Engineering Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Genetic Engineering Drug Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Genetic Engineering Drug Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Genetic Engineering Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Genetic Engineering Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 39. United States Genetic Engineering Drug Market Share by Application in 2022 & 2028
    Figure 40. United States Genetic Engineering Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Genetic Engineering Drug Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Genetic Engineering Drug Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Genetic Engineering Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Genetic Engineering Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 45. North America Genetic Engineering Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Genetic Engineering Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Genetic Engineering Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Genetic Engineering Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Genetic Engineering Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Genetic Engineering Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Genetic Engineering Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Genetic Engineering Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Genetic Engineering Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Genetic Engineering Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Genetic Engineering Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Genetic Engineering Drug Value Chain
    Figure 79. Genetic Engineering Drug Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed